OctoPlus N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
09 jan 2007 - 00:19
Statutaire naam
OctoPlus N.V.
Titel
OctoPlus announces official opening of Boston office
Bericht
OctoPlus N.V. (Euronext: OCTO), the drug
delivery and development company, announces today the official opening of its business
development office in Boston.
A large and growing part of OctoPlus’ clients is located in North America. With the office in
Boston, OctoPlus aims to better service those clients and further expand its business in North
America. The office will be operated by OctoPlus Inc., a wholly owned subsidiary of OctoPlus
N.V. The Boston office will support OctoPlus’ drug development activities as well as its drug
formulation and manufacturing business.
OctoPlus has appointed Michiel Lodder, Ph.D., as Director Business Development, North-
America. Dr. Lodder was previously Manager Business Development and Project Leader at
OctoPlus’ headquarters in Leiden, the Netherlands.
“We are very happy that OctoPlus has a presence in North America now,” says Joost
Holthuis, CEO of OctoPlus. “We want to continue to expand our business in that region and
with a local office, we can better support our clients and maximize the commercial
opportunities there.”
Datum laatste update: 23 februari 2026